Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 079011
Company: TEVA PHARMS USA

Products on ANDA 079011

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FLUVASTATIN SODIUM	FLUVASTATIN SODIUM	EQ 80MG BASE	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 079011

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/27/2016	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/24/2024	SUPPL-7	Labeling-Medication Guide, Labeling-Patient Package Insert, Labeling-Package Insert		Label is not available on this site.
02/02/2023	SUPPL-6	Labeling-Package Insert, Labeling-Patient Package Insert		Label is not available on this site.
02/02/2023	SUPPL-2	Labeling-Package Insert, Labeling-Patient Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 079011

FLUVASTATIN SODIUM

TABLET, EXTENDED RELEASE;ORAL; EQ 80MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
FLUVASTATIN SODIUM	FLUVASTATIN SODIUM	EQ 80MG BASE	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	209397	BEIJING
FLUVASTATIN SODIUM	FLUVASTATIN SODIUM	EQ 80MG BASE	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	079011	TEVA PHARMS USA
LESCOL XL	FLUVASTATIN SODIUM	EQ 80MG BASE	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	021192	SANDOZ